CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

TP53 deletion / del(17p) (chronic lymphocytic leukemia)

Gene: TP53 · Type: deletion

Indications: Chronic lymphocytic leukemia

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
VenetoclaxChronic lymphocytic leukemiaINDICATED
FDA Label
Label
IbrutinibChronic lymphocytic leukemiaINDICATED
FDA Label
Label
AcalabrutinibChronic lymphocytic leukemiaINDICATED
FDA Label
Label
ZanubrutinibChronic lymphocytic leukemiaINDICATED
FDA Label
Label